tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (AU:TLX)
:TLX
Australian Market

Telix Pharmaceuticals (TLX) Income Statement

Compare
324 Followers

Telix Pharmaceuticals Income Statement

Last quarter (Q4 2024), Telix Pharmaceuticals's total revenue was AU$594.24M, an increase of 336.79% from the same quarter last year. In Q4, Telix Pharmaceuticals's net income was AU$38.24M. See Telix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60MAU$ 5.21M
Gross Profit
AU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77MAU$ -16.88M
Operating Expenses
AU$ 427.55MAU$ 263.27MAU$ 102.52MAU$ 51.48MAU$ 32.38M
Depreciation and Amortization
AU$ 0.00AU$ 6.74MAU$ 5.38MAU$ 5.17MAU$ 4.88M
EBITDA
AU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -44.94M
Operating Income
AU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25M
Other Income/Expenses
AU$ -26.07MAU$ -48.80MAU$ -24.52MAU$ -17.79MAU$ -11.00M
Pretax Income
AU$ 56.06MAU$ 3.09MAU$ -98.62MAU$ -99.04MAU$ -60.25M
Net Income
AU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89M
Per Share Metrics
Basic EPS
AU$ 0.15AU$ 0.02AU$ -0.34AU$ -0.29AU$ -0.17
Diluted EPS
AU$ 0.14AU$ 0.02AU$ -0.34AU$ -0.29AU$ -0.17
Weighted Average Shares Outstanding
331.23M 319.18M 310.64M 282.21M 257.27M
Weighted Average Shares Outstanding (Diluted)
345.19M 323.71M 310.64M 282.21M 257.27M
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis